Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanwen Yao

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Plos One|January 4, 2013
Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in miceXingqun Ma, Yanwen Yao, Dongmei Yuan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2015
The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancersChenhui Ma, Xuefei Shi, Qingqing Zhu, et al.
Plos One|May 5, 2015
A serum vitamin D level <25nmol/l pose high tuberculosis risk: a meta-analysisJunli Zeng, Guannan Wu, Wen Yang, et al.
Molecular Carcinogenesis|December 21, 2013
A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancerXuefei Shi, Ming Sun, Hongbing Liu, et al.
Translational Lung Cancer Research|November 14, 2025
The granulomatous pulmonary nodules induced by tislelizumab in advanced squamous NSCLC: a case report with challenging differential diagnosisYangyang Ma, Xinxin Chen, Yan Liang, et al.
Translational Lung Cancer Research|June 15, 2026
Case report: first-line lorlatinib in metastatic lung adenocarcinoma with a novel WIPF1-ALK and EML4-ALK dual fusionSili Wang, Xinxin Chen, Yangyang Ma, et al.
Translational Cancer Research|February 4, 2022
Diagnosis status and pathological diagnosis derived treatment of elderly lung cancer patients over 75 years oldGuannan Wu, Xiaoling Gu, Dongmei Yuan, et al.
Medical Oncology (Northwood, London, England)|October 14, 2011
MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significanceLiang Luo, Ting Zhang, Hongbing Liu, et al.
Journal of Thoracic Disease|January 11, 2014
Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancerHongbing Liu, Ying Wu, Zhaofeng Wang, et al.
Free Radical Biology & Medicine|March 17, 2015
Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathwayXiaoling Gu, Guannan Wu, Yanwen Yao, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Plos One|January 4, 2013
Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in miceXingqun Ma, Yanwen Yao, Dongmei Yuan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2015
The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancersChenhui Ma, Xuefei Shi, Qingqing Zhu, et al.
Plos One|May 5, 2015
A serum vitamin D level <25nmol/l pose high tuberculosis risk: a meta-analysisJunli Zeng, Guannan Wu, Wen Yang, et al.
Molecular Carcinogenesis|December 21, 2013
A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancerXuefei Shi, Ming Sun, Hongbing Liu, et al.
Translational Lung Cancer Research|November 14, 2025
The granulomatous pulmonary nodules induced by tislelizumab in advanced squamous NSCLC: a case report with challenging differential diagnosisYangyang Ma, Xinxin Chen, Yan Liang, et al.
Translational Lung Cancer Research|June 15, 2026
Case report: first-line lorlatinib in metastatic lung adenocarcinoma with a novel WIPF1-ALK and EML4-ALK dual fusionSili Wang, Xinxin Chen, Yangyang Ma, et al.
Translational Cancer Research|February 4, 2022
Diagnosis status and pathological diagnosis derived treatment of elderly lung cancer patients over 75 years oldGuannan Wu, Xiaoling Gu, Dongmei Yuan, et al.
Medical Oncology (Northwood, London, England)|October 14, 2011
MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significanceLiang Luo, Ting Zhang, Hongbing Liu, et al.
Journal of Thoracic Disease|January 11, 2014
Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancerHongbing Liu, Ying Wu, Zhaofeng Wang, et al.
Free Radical Biology & Medicine|March 17, 2015
Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathwayXiaoling Gu, Guannan Wu, Yanwen Yao, et al.
Pageof 5